HR 2343 · in committee · significant
John W. Walsh Alpha-1 Home Infusion Act of 2025
- healthcare
What this bill does
- Medicare will cover at-home augmentation therapy for patients with emphysema from alpha-1 antitrypsin deficiency.
- This affects Medicare beneficiaries with severe hereditary AAT deficiency who need ongoing treatment.
- Coverage requires treatment through qualified home infusion suppliers under physician supervision.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would expanding Medicare coverage for home infusion therapy affect treatment accessibility for patients currently unable to afford alpha-1 antitrypsin augmentation?
- 02
What evidence demonstrates that home-based infusion therapy produces comparable health outcomes to clinic-based treatment for alpha-1 antitrypsin deficiency?
- 03
How would Medicare's costs change if this coverage expansion increases the number of eligible patients receiving augmentation therapy?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-FL-27
Maria Elvira Salazar
Citizen cosponsors
0
In Congress
52/ 435
House Reps cosponsoring
Introduced 2025-03-25
Joining the bill
Henry C. "Hank" Johnson, Jr.
D-GA-4 · original
Eleanor Holmes Norton
D-DC · original
Paul Tonko
D-NY-20 · original
Young Kim
R-CA-40 · original
Chellie Pingree
D-ME-1 · original
Christopher H. Smith
R-NJ-4 · original
David Rouzer
R-NC-7 · original
Burgess Owens
R-UT-4 · original
Timothy M. Kennedy
D-NY-26
Michael Lawler
R-NY-17
Nicholas A. Langworthy
R-NY-23
Raul Ruiz
D-CA-25
+ 40 more
Legislative timeline
2025-03-25 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-25 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-25 · IntroReferral
Introduced in House
2025-03-25 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.